NMPA Approval

Bendamustine Hydrochloride for Injection

Approval Number

国药准字H20227059

Company正大天晴药业集团股份有限公司

Registration Date

April 27, 2022

Previous Approval Numbers

国药准字H20193358

Drug Information

Generic Name

注射用盐酸苯达莫司汀

Dosage Form

注射剂

Strength

100mg

Drug Type

化学药品

Registration Date

April 27, 2022

Company Information

Applicant Company

Company Name正大天晴药业集团股份有限公司

Company Address

江苏省连云港市郁州南路369号

Manufacturing Company

Company Name正大天晴药业集团股份有限公司

Company Address

江苏省连云港市郁州南路369号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

注射用盐酸苯达莫司汀 - NMPA 批准文号 | MedPath